Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111 Meeting Abstract
| Authors: | Makker, V.; Taylor, M. H.; Aghajanian, C.; Cohn, A. L.; Brose, M. S.; DiSimone, C.; Cao, A.; Suttner, L.; Loboda, A.; Cristescu, R.; Jelinic, P.; Snyder, A.; Nebozhyn, M.; Lunceford, J.; Orlowski, R.; Dutta, L.; Matsui, J.; Dutcus, C.; Minoshima, Y.; Messing, M. |
| Abstract Title: | Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111 |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S760 |
| Language: | English |
| ACCESSION: | WOS:000700527701261 |
| DOI: | 10.1016/j.annonc.2021.08.1238 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #796P -- Source: Wos |
